News

  • Investor appetite for digital health hits new high

    Digital health venture funding hit a record US$6.7bn in the US in the first quarter of the year, data shows. This compares to US$4.1bn and US$4bn in Q3 and Q4 2020 respectively - and puts 2021 well on track to eclipse last year’s total of US$14bn in US-based digital health venture funding. Meanwhile, average deal [...]

  • Scientists create atlas of human genome variants

    An international consortium of geneticists, biologists, clinicians, mathematicians, and other scientists is determined to take the study of the human genome to the next level. It is creating a comprehensive atlas of genetic variants to advance the understanding, diagnosis, and treatment of disease. "This Herculean undertaking is unprecedented," said Dr. Matthew Hurles, a geneticist at [...]

  • Social media platforms urged to step up mental health protection

    Two thirds of social media users want better mental health protection, a study suggests. Two thirds of UK adults with a social media account believe social media companies have a duty to protect the mental health of people who use their platforms, according to new research. 4,000 people were surveyed by wellbeing company Soul Analyse [...]

  • How hearing aids could tackle stress and heart problems

    Hearing aid technology could help to reduce stress, according to a new report that also suggests it could be modified to reduce raised heart rates. Danish hearing aid manufacturer Oticon has published research showing hearing aids can potentially reduce the impact of noise on a person’s stress levels. The study provides a glimpse into the future [...]

  • Targeting protein could lead to new breast cancer treatments

    A protein frequently found in high levels in breast cancer cells helps tumours to survive and grow, and could be targeted with a new type of drug that is already being tested for other cancers, new research reveals. The new study confirms that a protein called MCL-1 helps breast cancer cells survive, by hindering cells’ natural ability [...]

  • English trust signs Synopsis digital deal

    South Tees Hospitals NHS Foundation Trust, in north-east England, has agreed a five-year deal with Synopsis that will see its paper-based pre-operative process become entirely digital. The trust will launch Synopsis Home and Synopsis iQ at The James Cook University Hospital in Middlesbrough and the Friarage Hospital in Northallerton in the coming months. Synopsis iQ will allow [...]

  • Covid has forced innovation into all aspects of daily life – including health

    Jack Priestman, co-founder of Salient Bio, on how the pandemic has prompted a more proactive shift towards diagnosis for health issues. The pandemic has totally changed how we navigate everyday life, and while the rollout of vaccines marks the sense of a return to normality, some shifts feel more like a permanent evolution rather than temporary [...]

  • UK events series goes global

    A UK series of health innovation events is being expanded globally. Future Health Innovation, which runs the Health Week Series, has announced upcoming events in the UAE, India and locations in Africa and Asia, as well as summer and winter events in the UK. The Health Week Series brings together online networking events and conferences [...]

  • NHS security skills up, but inconsistencies hold up progress

    The number of NHS trust staff with IT security qualifications has almost doubled since 2018, new data suggests. The research also shows that trusts reported an average of two breaches to the Information Commissioner’s Office in 2020, a slight drop from 2019 (2.5). Meanwhile, the majority (83 per cent) of trusts commissioned at least one [...]

  • Oxehealth launches in the US after FDA clearance

    Vision-based patient monitoring and management company will focus on skilled nursing facilities, where its technology service can help clinicians deliver safer, higher quality and more efficient care. Oxehealth has announced a world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into [...]